Section 16 Filings :: NeoGenomics, Inc. (NEO)

NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Menu

Test Search

Filing Type

Year

SEC Filings
Date	Form	Description	XBRL	Pages